NASDAQ: IDXX
Idexx Laboratories Revenue

Idexx Laboratories revenue was $3.84B for the trailing 12 months ending Sep 30, 2024, with 5.7% growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $975.5M, down 2.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, IDXX annual revenue was $3.7B, with 8.7% growth year-over-year.

IDXX past revenue growth

How has IDXX's revenue growth performed historically?

Company
7.16%
Industry
1.05%
Market
34.78%
IDXX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IDXX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IDXX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IDXX revenue history

Current Revenue
$3.8B
Current Earnings
$866.2M
Current Profit Margin
22.5%
IDXX's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when IDXX announces revenue.

IDXX Revenue History By Year

IDXX Yearly RevenueIDXX RevenueIDXX ChangeIDXX Revenue Growth
2023-12-31$3.66B$293.63M+8.72%
2022-12-31$3.37B$151.96M+4.73%
2021-12-31$3.22B$508.71M+18.79%
2020-12-31$2.71B$299.75M+12.45%
2019-12-31$2.41B$193.67M+8.75%
2018-12-31$2.21B$244.18M+12.40%
2017-12-31$1.97B$193.64M+10.91%
2016-12-31$1.78B$173.53M+10.83%
2015-12-31$1.60B$116.09M+7.81%
2014-12-31$1.49B$108.75M+7.90%
2013-12-31$1.38B$83.72M+6.47%
2012-12-31$1.29B$74.65M+6.13%
2011-12-31$1.22B$115.30M+10.45%
2010-12-31$1.10B$71.76M+6.96%
2009-12-31$1.03B$7.60M+0.74%
2008-12-31$1.02B$101.48M+11.00%
2007-12-31$922.56M$183.44M+24.82%
2006-12-31$739.12M$101.02M+15.83%
2005-12-31$638.10M$88.91M+16.19%
2004-12-31$549.18M$73.19M+15.38%
2003-12-31$475.99M$63.32M+15.34%
2002-12-31$412.67M$26.59M+6.89%
2001-12-31$386.08M$18.65M+5.08%
2000-12-31$367.43M$9.06M+2.53%
1999-12-31$358.37M$36.66M+11.39%
1998-12-31$321.71M$58.74M+22.34%
1997-12-31$262.97M-$4.71M-1.76%
1996-12-31$267.68M$79.08M+41.93%
1995-12-31$188.60M$62.24M+49.25%
1994-12-31$126.36MN/AN/A

1 of 2

Idexx Laboratories Revenue FAQ

What was IDXX's revenue last quarter?

On Invalid Date, Idexx Laboratories (NASDAQ: IDXX) reported Q3 2024 revenue of $975.54 million up 6.56% year over year. In the same quarter last year, Idexx Laboratories's revenue was $915.53 million.

What was Idexx Laboratories's revenue in 2023?

Idexx Laboratories's annual revenue for the twelve months ending Dec 31, 2023 was $3.66 billion, a 8.72% increase year over year.

How much does Idexx Laboratories make in a day?

Based on Idexx Laboratories annual revenue for the past five years, IDXX makes an average of $8,414,904.11 per day.

What was Idexx Laboratories's annual revenue growth in the past year?

As of Q1 2025, Idexx Laboratories's revenue has grown 7.16% year over year. This is 6.11 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 1.05%. Idexx Laboratories's revenue in the past year totaled $3.84 billion.

How much does Idexx Laboratories make in a year?

Idexx Laboratories's revenue by year for the past five years is:
  • Idexx Laboratories's revenue for the twelve months ending Dec 31, 2023 was $3.66 billion, a 8.72% increase year over year.
  • Idexx Laboratories's annual revenue for Dec 31, 2022 was $3.37 billion, a 4.73% increase from 2021.
  • Idexx Laboratories's annual revenue for 2021 was $3.22 billion, a 18.79% increase from 2020.
  • Idexx Laboratories's annual revenue for 2020 was $2.71 billion, a 12.45% increase from 2019.
  • Idexx Laboratories's annual revenue for 2019 was $2.41 billion, a 8.75% increase from 2018.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.